Jonae R. Barnes
Contatto Relazioni con gli Investitori presso ATEA PHARMACEUTICALS, INC.
Posizioni attive di Jonae R. Barnes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Contatto Relazioni con gli Investitori | 19/01/2021 | - |
| Public Communications Contact | 19/01/2021 | - |
Storia della carriera di Jonae R. Barnes
Precedenti posizioni note di Jonae R. Barnes
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Contatto Relazioni con gli Investitori | 01/01/2007 | 01/12/2009 |
| Public Communications Contact | 01/01/2007 | 01/12/2009 | |
| POXEL | Contatto Relazioni con gli Investitori | 14/03/2016 | - |
| Public Communications Contact | 14/03/2016 | - | |
| AGENUS INC. | Contatto Relazioni con gli Investitori | 01/01/2011 | - |
| IDENIX PHARMACEUTICALS INC | Contatto Relazioni con gli Investitori | - | - |
| Public Communications Contact | 29/10/2010 | - |
Formazione di Jonae R. Barnes
| Suffolk University | Undergraduate Degree |
| Boston University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Francia | 2 |
Posizioni
| Investor Relations Contact | 5 |
| Public Communications Contact | 4 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AGENUS INC. | Health Technology |
| POXEL | Health Technology |
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jonae R. Barnes
- Esperienza
